WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsOPTIMIZERx Corp (OPRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 2537% more annual revenue ($2.89B vs $109.43M). OPRX leads profitability with a 4.7% profit margin vs -7.3%. OPRX earns a higher WallStSmart Score of 49/100 (D+).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

OPRX

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 6.0Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MMED.

OPRXSignificantly Overvalued (-401.6%)

Margin of Safety

-401.6%

Fair Value

$1.84

Current Price

$6.78

$4.94 premium

UndervaluedFair: $1.84Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

OPRX2 strengths · Avg: 9.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Operating MarginProfitability
27.7%8/10

Strong operational efficiency at 27.7%

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

OPRX4 concerns · Avg: 3.3/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

Market CapQuality
$120.64M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.2%3/10

ROE of 4.2% — below average capital efficiency

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : OPRX

The strongest argument for OPRX centers on Price/Book, Operating Margin.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : OPRX

The primary concerns for OPRX are PEG Ratio, Market Cap, Return on Equity. Thin 4.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

MMED profiles as a turnaround stock while OPRX is a value play — different risk/reward profiles.

MMED is growing revenue faster at 13.1% — sustainability is the question.

OPRX generates stronger free cash flow (7M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

OPRX scores higher overall (49/100 vs 37/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

OPTIMIZERx Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

OptimizeRx Corporation is a digital health company providing communications solutions for life sciences companies, physicians, and patients. The company is headquartered in Rochester, Michigan.

Want to dig deeper into these stocks?